Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Movers

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Movers

12 Industrials Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
October 6, 2:42 PM
Gainers

AERC

Read More
2 minute read
  • Movers

12 Information Technology Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights
October 6, 2:41 PM
Gainers

BBAI

Read More
1 minute read
  • Global
  • Movers
  • News
  • Trading Ideas

What’s Going On With Nio Stock Today?

By Adam Eckert
October 6, 2:28 PM
NIO Inc (NYSE: NIO) shares are trading lower Thursday after Mizuho slightly cut its price target on the stock in the wake of the company's most recent delivery numbers.&nb

NIO

Read More
1 minute read
  • Movers
  • News
  • Trading Ideas

Walmart Says On October 17 Will Begin Offering Over-The-Counter (OTC) Hearing Aids

By Benzinga Newsdesk
October 6, 2:01 PM
-Reuters

EAR

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

This Analyst Cuts Integer’s Price Target Citing Choppy Macro Environment

By Vandana Singh
October 6, 1:38 PM
Integer Holdings Corp (NYSE:ITGR) said Q3 sales were negatively impacted by approximately $15 million, primarily due to deteriorating delivery performance and…

ITGR

Read More
1 minute read
  • Movers
  • News
  • Trading Ideas

California-Focused Oil Producer Berry Corp Exploring Strategic Options Including Sale

By Benzinga Newsdesk
October 6, 1:10 PM
-Reuters

BRY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction

By Vandana Singh
October 6, 12:46 PM
Cyclerion Therapeutics Inc (NASDAQ:CYCN) is reprioritizing development programs and focusing resources and capabilities on candidates for mitochondrial diseases. The company has…

CYCN

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Why Cyclerion Therapeutics Stock Is Getting Hammered

By Henry Khederian
October 6, 12:13 PM
Cyclerion Therapeutics Inc (NASDAQ: CYCN) shares are trading lower by 43.33% to $0.53 during Thursday's trading session after the company announced a mitochondrial disease-focused strategy. The plan will include a 45% workforce reduction. What Else?

CYCN

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Why Revelation Biosciences Stock Is Popping Off

By Henry Khederian
October 6, 11:41 AM
Revelation Biosciences Inc (NASDAQ: REVB) shares are trading higher after the company announced an exclusive worldwide license agreement with Vanderbilt University to develop and commercialize phosphorylated hexaacyl disaccharide, for treating or preventing infections.

REVB

Read More
1 minute read
  • Movers
  • Small Cap
  • Trading Ideas

Why Provention Bio Shares Are Skyrocketing Today

By Henry Khederian
October 6, 11:40 AM
Provention Bio Inc (NASDAQ: PRVB) shares are trading higher by 20.6% to $5.97 Thursday morning after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch of its lead investigational drug candidate teplizumab. What Else?

PRVB

Posts pagination

Previous 1 … 2,036 2,037 2,038 … 2,348 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service